Over the past few decades, the life expectancy of Mexicans has increased considerably and, accordingly, chronic-degenerative health issues are also on the rise, including diabetes, hypertension, hepatic diseases and cancer, among many others that form part of the field of Internal Medicine and its related subspecialties. At the same time, globalization, advancements in knowledge of biology, genomics and proteomics, the development of new information and communication technologies and systems, social networks, changes in epidemiology, advancements in therapeutics and the growing cost of health services could signify a radical change in the way diseases are addressed in this generation. Today more than ever before, Internal Physicians? practice must be based on science and evidence. They will undoubtedly focus on preventive and ambulatory medicine, maintaining their position in intra-hospital medicine as the health-team leader and mentoring doctors who want to study a subspecialty related to internal medicine. Tecnológico de Monterrey?s educational process is centered on the acquisition of knowledge and development of the skills, attitudes and values that will enable students to grow as individuals, committed to their community and acting as agents of change to improve it in the area of their specialty, and to keep up-to-date in a changing environment. The curricular content and competencies are developed by the students throughout the four-year program, incorporating during this period the knowledge, skills, attitudes and values required of a good internist. Clinical activities are executed in both public (Hospital Metropolitano) and private (Hospital San José de Monterrey and Centro Médico Zambrano Hellion) settings, thus offering a wide-ranging panorama of Medicine in our region and providing opportunities for national and/or international rotations to extend this panorama.
The aim of the Residency in Internal Medicine of Tecnológico de Monterrey is to train exceptional Internists who meet the health needs of adult patients, according to the highest quality and safety standards, in both inpatient and outpatient settings. It also seeks to prepare individuals with integrity and a humanistic outlook in their clinical, teaching and research practice, while strictly adhering to ethical principles and the standards of professional practice. Internists who graduate from this institution are outstanding leaders locally and internationally, who contribute to the continuous enhancement of healthcare processes and to generating innovations in the primary or secondary prevention of disorders that affect the adult population, in particular chronic-degenerative diseases.
The Multicentric Internal Medicine Program of Tecnológico de Monterrey targets academically outstanding graduates from the Physician and General Surgeon undergraduate program, with a vocation and concern for this discipline, and a genuine interest in research and teaching.
For admission to the Residency in Internal Medicine of the School of Medicine and Health Sciences of Tecnológico de Monterrey, candidates must satisfactorily meet all the graduate admissions requirements of Tecnológico de Monterrey and of the Ministry of Health.
Comply with the comprehensive evaluation required in the admission process, through an interview conducted by the admissions committee of the graduate program. In addition, the following is necessary:
*The admission process may change without prior notice from the Admissions Committee
**Admission is the first step: then you can enroll in your graduate program of interest.
Face to Face
Internal Medicine is the medical specialty that addresses healthcare in adult patients and forms the basis of subspecialties related to attending diseases of the different organs or systems of the human body. The Residency in Internal Medicine Program seeks to prepare practitioners with the following competencies:
Digestive Tube Motility: Reflux disease, defecation disorders. Research and evaluation of the different diagnostic methods, including phmetry, impedance, manometry, biopsy, and other studies.
The current diet and lifestyle have increased the frequency of reflux disease which has a great impact on quality of life and treatment costs. For this reason, we consider it extremely important to implement and optimize the protocol for the study and treatment of patients who suffer from it. On the other hand, the increase in life expectancy has made problems that were not given much attention, become relevant and the center of discussion. Among these are defecation disorders (constipation and incontinence), which, although not exclusive to adults, do have a negative impact on quality of life, work capacity and the use of health services and the cost of medications. and treatments. So, through this line of research, we seek to improve the quality of life of our patients for their reintegration into a productive life.
It includes scales and a combination of them, for the identification of risk or severity in different diseases, including clinical, biochemical, and molecular markers.
For the design of protocols for the diagnosis and treatment of various diseases, particularly those with a high potential for the development of complications, it is ideal to have markers for the diagnosis, the establishment of severity and the potential for the development of complications, for which we consider the search for scales, markers and a combination of them that help us improve the process of patient care is very relevant.
Non-communicable diseases are the cause of 70% of deaths worldwide. Many of these deaths are premature, especially in developing countries. These include cardiovascular diseases, cancer, chronic lung diseases, and diabetes. Detection, screening, and treatment, like palliative care, are essential components of the response to NCDs. This line studies the pathologies that, due to their frequency and importance, require delving into the study of the pathophysiological mechanisms that originate them, thus seeking to resolve them through the application of new diagnostic and therapeutic measures.
Communicable diseases include HIV/AIDS, Sexually Transmitted Infections (STIs), and viral hepatitis; Tuberculosis; malaria and other vector-borne diseases; neglected, tropical and zoonotic diseases and vaccine-preventable diseases. Up to 34 million people worldwide are currently infected with the human immunodeficiency virus, and more than 250 other communicable diseases identified worldwide. The increase in communicable diseases and the reappearance of many of them such as malaria and tuberculosis, and the growing threat of biological terrorism is imminent to encourage research and surveillance regarding their presentation and distribution.